Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1801

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 1801
---

Option Grants

On
January 1, 2023, the Company granted non-qualified stock option to purchase 562,500 of common stock to Saleem Elmasri, CPA, as Chief
Financial Officer, at an exercise price of $1.33 per share.

On
September 29, 2023, the Company granted non-qualified stock options to purchase 710,344 of common stock to Christer Rosén at an
exercise price of $1.33 per share.

On
September 29, 2023, the Company granted non-qualified stock options to purchase 556,673 of common stock to Marshall Hayward at an exercise
price of $1.33 per share.

On
September 29, 2023, the Company granted non-qualified stock options to purchase 81,600 of common stock to Saleem Elmasri, CPA at an exercise
price of $1.33 per share.

On
December 18, 2023, the Company granted non-qualified stock options to purchase 88,909 of common stock to Christer Rosén at an
exercise price of $1.33 per share.

On
December 18, 2023, the Company granted non-qualified stock options to purchase 69,675 of common stock to Marshall Hayward at an exercise
price of $1.33 per share.

On
December 18, 2023, the Company granted non-qualified stock options to purchase 22,320 of common stock to Saleem Elmasri, CPA at an exercise
price of $1.33 per share.

Other
Benefits

In
2024 and 2023, our NEOs were reimbursed for healthcare expenses. The amounts paid to our NEOs in respect of these benefits is reflected
above in “—2024 Summary Compensation Table.”

2023
Equity Incentive Plan

Overview

The
Board of Directors and shareholders holding a majority of the Company’s voting capital approved and adopted the 2023 Equity Incentive
Plan (the “2023 Plan”) on October 4, 2023, respectively. The 2023 Plan authorizes the issuance of up to an aggregate maximum
of 4,012,785 shares of the common stock, subject to adjustment as described in the 2023 Plan. The 2023 Plan shall be administered by
the Board or one or more committees appointed by the Board or another committee (“Administrator”). The Administrator, in
its discretion